AU6901191A - Pharmacologically active substance bpc, the process for its preparation and its use in the therapy - Google Patents

Pharmacologically active substance bpc, the process for its preparation and its use in the therapy

Info

Publication number
AU6901191A
AU6901191A AU69011/91A AU6901191A AU6901191A AU 6901191 A AU6901191 A AU 6901191A AU 69011/91 A AU69011/91 A AU 69011/91A AU 6901191 A AU6901191 A AU 6901191A AU 6901191 A AU6901191 A AU 6901191A
Authority
AU
Australia
Prior art keywords
therapy
preparation
active substance
pharmacologically active
substance bpc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69011/91A
Inventor
Marko Duvnjak
Jerka Jukic
Simun Krizanac
Stjepan Mise
Marijan Petek
Ivo Rotkvic
Predrag Sikiric
Ernest Suchanek
Ivan Udovicic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP90119376A external-priority patent/EP0432400B1/en
Application filed by Individual filed Critical Individual
Publication of AU6901191A publication Critical patent/AU6901191A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
AU69011/91A 1990-09-11 1990-11-13 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy Abandoned AU6901191A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
WOEP9001533 1990-09-11
EP90119376A EP0432400B1 (en) 1989-09-12 1990-09-11 Pharmacologically active substance BPC, the process for its preparation and its use in the therapy
EP90119376 1990-09-11
EP9001533 1990-09-11

Publications (1)

Publication Number Publication Date
AU6901191A true AU6901191A (en) 1992-03-30

Family

ID=26069797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69011/91A Abandoned AU6901191A (en) 1990-09-11 1990-11-13 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy

Country Status (6)

Country Link
JP (1) JP2591875B2 (en)
AU (1) AU6901191A (en)
BG (1) BG61191B1 (en)
HU (1) HU217541B (en)
RU (1) RU2104704C1 (en)
WO (1) WO1992004368A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277948T1 (en) * 1997-05-23 2004-10-15 Predrag Sikiric BPC PEPTIDE SALTS WITH ORGAN-PROTECTIVE ACTIVITY, THEIR PRODUCTION AND THERAPEUTIC USE
KR20030067435A (en) * 2002-02-06 2003-08-14 유지고하라 Energy Converting Polar Plate and Method of Manufacturing
KR20030076007A (en) * 2002-03-22 2003-09-26 유지고하라 Change device of heat energy
US10350293B2 (en) * 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
CN114632092B (en) * 2022-05-17 2022-08-23 北京第一生物化学药业有限公司 Application of testis tablet in preparing medicine with hypoglycemic activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1279820A (en) * 1968-12-26 1972-06-28 Nissui Pharm Co Ltd Process for preparing mucoprotein and product obtained thereby

Also Published As

Publication number Publication date
JP2591875B2 (en) 1997-03-19
HU217541B (en) 2000-02-28
BG61191B1 (en) 1997-02-28
HUT61320A (en) 1992-12-28
WO1992004368A1 (en) 1992-03-19
RU2104704C1 (en) 1998-02-20
HU9201941D0 (en) 1992-09-28
JPH05503089A (en) 1993-05-27

Similar Documents

Publication Publication Date Title
AU6734990A (en) Freeze-dried dosage forms and methods for preparing the same
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
AU6901191A (en) Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
AU7793791A (en) Pharmaceutical composition for use in treating pain
ZA894422B (en) Pyrrole derivatives,their preparation and their use as pharmaceutical active compounds
HUP0002329A3 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
AU627033B2 (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives, their preparation and their application in therapy
ZA907398B (en) Pharmacologically active compound,preparation and use
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
EP0583698A3 (en) Deoxycyclitol derivatives, process for their preparation and their use in medicaments.
GR900300003T1 (en) 3-aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use
AU1119892A (en) Physiologically active kanglemycin c, process for preparing the same and use thereof
EP0477717A3 (en) New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
AU7534787A (en) Pharmacologically active compounds and use
ZA907628B (en) 3-isoxazolone derivatives,their preparation and their therapeutic uses
AU3499293A (en) L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy